CA
NZ
UK
AU
IND
US
Syndax is a New York City-based commercial-stage oncology company founded in 2005 that develops first-in-class therapies for acute leukemia and chronic graft-versus-host disease. Its two FDA-approved medicines are Revuforj, the first menin inhibitor, approved for relapsed or refractory KMT2A-translocated acute leukemia and NPM1-mutant AML, …
Tactile Systems Technology, which doesBusinessas Tactile Medical, is a Minneapolis-based company that develops and sells at-home medical devices for underserved chronic conditions. Its main products are the Flexitouch Plus, Entre Plus and Nimbl pneumatic compression systems for lymphedema and chronic venous insufficiency, plus the …
Thermo Fisher is a Waltham, Massachusetts-based science and diagnostics company that generated about $44.56 billion in revenue in 2025. It operates through Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services, selling under brands including Thermo Scientific, Applied Biosystems, Invitrogen, …
VivoSim Labs, formerly Organovo Holdings, is a San Diego-based biotechnology services company that tests drugs and drug candidates in its NAMkind 3D human liver and intestinal tissue models, combined with AI-driven analytics and toxicology expertise. It serves pharmaceutical and biotech partners seeking human-relevant safety …
AdaptHealth is a Conshohocken, Pennsylvania-based provider of home medical equipment, medical supplies and related services. It operates Sleep Health, Respiratory Health and Wellness at Home segments through about 660 locations in 48 states, reaching approximately 4.8 million patients annually.
Inovio, based in Plymouth Meeting, Pennsylvania, is a biotechnology company developing DNA medicines for HPV-related diseases, cancer and infectious diseases. Its platform pairs SynCon-engineered DNA plasmids with the proprietary CELLECTRA smart device, which delivers the plasmids into cells without lipid nanoparticles or viral vectors. …
Madrigal is a West Conshohocken, Pennsylvania-based commercial-stage biopharmaceutical company focused on metabolic dysfunction-associated steatohepatitis, or MASH. Rezdiffra (resmetirom) is a once-daily, oral, liver-directed THR-beta agonist and the first medication approved by the FDA and the European Commission for MASH with moderate to advanced fibrosis. …
Revvity, headquartered in Waltham, Massachusetts and formerly known as PerkinElmer, is an S&P 500 health science and diagnostics company. It rebranded in 2023 after divesting its applied, food and enterprise services businesses. It reports Life Sciences and Diagnostics segments, has about 11,000 employees and …
Travere is a San Diego-based biopharmaceutical company focused on rare kidney and metabolic diseases. FILSPARI is a once-daily oral dual endothelin and angiotensin II receptor antagonist approved in the U.S. for IgA nephropathy and, as of April 2026, focal segmental glomerulosclerosis, where it became …
Inovio shares are trading up 223.69% at $1.95, against a previous close of $0.60, after the FDA grantedAccelerated Approvalto VOCERYQ for adults with recurrent respiratory papillomatosis. The company calls it the first FDA-approved DNA medicine, for a disease that causes wart-like growths in the …
Please wait processing your request...